Subcutaneous Allergen Immunotherapy May Provide Mild Protective Effect Against COVID-19, Research Letter Says

Healio (6/30, Gawel) reported, “Subcutaneous immunotherapy for house dust mite allergy may slightly protect patients against SARS-CoV-2 infection, especially after the dose-escalation phase, according to a letter.” The research findings were published in...